Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72611 record(s)

Req # A-2019-001675

Adverse Reaction Report (AER). Report number: E2B_02658085.

Organization: Health Canada

14 page(s)
February 2020

Req # A-2019-001682

Adverse Reaction Report (AER) for DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE. Report number: 000721467.

Organization: Health Canada

3 page(s)
February 2020

Req # A-2019-001683

Adverse Reaction Report (AER). Report number: E2B_02613357.

Organization: Health Canada

54 page(s)
February 2020

Req # A-2019-001684

Adverse Reaction Report (AER). Report number: E2B_02608097.

Organization: Health Canada

8 page(s)
February 2020

Req # A-2019-001710

Adverse Reaction Report (AER) for ALUNBRIG. Report number: ALUNBRIG: E2B_02779985.

Organization: Health Canada

10 page(s)
February 2020

Req # A-2019-001723

Adverse Reaction Report (AER) for Mezavant. Report numbers: 000728451, 000729354, 000729436.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001727

Adverse Reaction Report (AER) for GAMMAGARD LIQUID. Report numbers: 000728962, 000728969, 000729342, 000729853, 000729855, 000728875, 000728906, 000728944, 000728949, 000730606, 000730608, 000730645, E2B_02786597, E2B_02790769, E2B_02791427.

Organization: Health Canada

65 page(s)
February 2020

Req # A-2019-001728

Adverse Reaction Report (AER) for GAMMAGARD S/D. Report numbers: 000730130, E2B_02747530, E2B_02747562.

Organization: Health Canada

59 page(s)
February 2020

Req # A-2019-001731

Adverse Reaction Report (AER) for BRIGATINIB. Report number: E2B_02781765.

Organization: Health Canada

13 page(s)
February 2020

Req # A-2019-001737

Adverse Reaction Report (AER) for PANTOLOC. Report numbers: E2B_02774280, E2B_02774302, E2B_02772419, E2B_02772402, E2B_02774439.

Organization: Health Canada

79 page(s)
February 2020
Date modified: